Induction therapy with ixekizumab may provide faster symptom relief but is associated with lower long-term drug survival due to higher baseline disease severity. The study analyzed 183 patients over ...
Learn the difference between induction and maintenance phases in ANCA-associated vasculitis (AAV) treatment, including what to expect from medications like rituximab (Rituxan).